{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT04578496","recordId":"NCT04578496","peptideSlug":"afamelanotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04578496-afamelanotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct04578496.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct04578496.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2020-10-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"afamelanotide","submittedDate":"2020-10-05","publishedAt":"2026-08-23","recordId":"NCT04578496","recordSha256":"439dbde67d094e306ef28607c9e784a5daede2b64cd14389e9e108b3af0a2d25","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04578496?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Design","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2020-10-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"afamelanotide","submittedDate":"2020-10-08","publishedAt":"2026-08-23","recordId":"NCT04578496","recordSha256":"e7fc18fb03b279ccb077eb574a2617e5a04ca6f6d37211cd96da542128b11ff8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04578496?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Outcome Measures (Results)","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2020-11-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"afamelanotide","submittedDate":"2020-11-02","publishedAt":"2026-08-23","recordId":"NCT04578496","recordSha256":"9a064af15bff1f79cef5d46791284fb26d6aac58b03e1db1111b5f2b6d1aae62","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04578496?a=3&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"e0e305d1b48ddf49824b9547eb407ee87170b761c7e4277f03b52a17390c5f6e"}}